Based on recent studies, this type of regulation may be particularly evident in cancer driven by MYC-N amplification and activation of inflammation-oriented NF-κB-driven pro-survival network [92], as well as activation of RTK- or TGF-β receptor-mediated oncogenic pathways [71,85,86,150,151]. This evidence concerns the gene MYC and cancer.